O-012The phase 3 KEYNOTE-181 study: pembrolizumab versus chemotherapy as second-line therapy for advanced esophageal cancer. (2nd July 2019)

Record Type:: Journal Article
Title:: O-012The phase 3 KEYNOTE-181 study: pembrolizumab versus chemotherapy as second-line therapy for advanced esophageal cancer. (2nd July 2019)
Main Title:: O-012The phase 3 KEYNOTE-181 study: pembrolizumab versus chemotherapy as second-line therapy for advanced esophageal cancer
Authors:: Metges, J
François, E
Shah, M
Adenis, A
Enzinger, P
Kojima, T
Muro, K
Bennouna, J
Hsu, C
Moriwaki, T
Kim, S
Lee, S
Kato, K
Shen, L
Qin, S
Ferreira, P
Wang, R
Bhagia, P
Kang, S
Doi, T
Abstract:
Is Part Of:: Annals of oncology. Volume 30(2019)Supplement 4
Journal:: Annals of oncology
Issue:: Volume 30(2019)Supplement 4
Issue Display:: Volume 30, Issue 4 (2019)
Year:: 2019
Volume:: 30
Issue:: 4
Issue Sort Value:: 2019-0030-0004-0000
Page Start:
Page End:
Publication Date:: 2019-07-02
Subjects:: Oncology -- Periodicals
616.992
Journal URLs:: https://www.journals.elsevier.com/annals-of-oncology ↗
http://ukcatalogue.oup.com/ ↗
DOI:: 10.1093/annonc/mdz154.011 ↗
Languages:: English
ISSNs:: 0923-7534
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 1043.320000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 12154.xml